References
- Schmidt E B. n-3 Fatty acids and the risk of coronary heart disease. Dan Med Bull 1997; 44: 1–22
- Dyerberg J, Bang H O, Stoffersen E, Monacada S, Vane J R. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?. Lancet 1978; 2: 117–19
- Endres S, De Caterina R, Schmidt E B, Kristensen S D. n-3 Polyunsaturated fatty acids: update 1995. Eur J Clin Invest 1995; 25: 629–38
- Vanhoutte P M, Shimokawa H, Boulanger C. Fish oil and the platelet—blood vessel wall interaction. World Rev Nutr Diet 1991; 66: 233–44
- Lerman A, Edwards B S, Hallet J W, Heublein D M, Sandberg S M, Burnett J C. Circulation and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991; 325: 997–1001
- Salomone O A, Elliott P M, Calvino R, Holt D, Kaski J C. Plasma immunoreactive endothelin concentration correlates with severity of coronary artery disease in patients with stable angina pectoris and normal ventricular function. JACC 1996; 28: 14–19
- Burr M L, Fehily A M, Gilbert J F, Rogers S, Holliday R M, Sweetnam P M, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfaction: diet and reinfarction trial (DART). Lancet 1989; 2: 757–61
- Therkelsen K, Jensen K A, Freundlich M, Thorshauge H, Bünemann L, Bøgeskov-Nielsen L. Endothelin-1 and cerebral blood flow: influence of hypoxia, hypercapnia and indomethacin on circulating endothelin levels in healthy volunteers. Scand J Clin Lab Invest 1994; 54: 441–51
- Levin E R. Endothelins. N Engl J Med 1995; 333: 356–63
- Tamirisa P, Frishman W H, Kumar A. Endothelin and endothelin antagonism: roles in cardiovascular health and disease. Am Heart J 1995; 130: 601–10
- Schut N H, Bilo H J, Popp-Snijders C, Goedhart P T, Wilmink J M. Erythrocyte deformability, endothelin levels, and renal function in cyclosporin-treated renal transplant recipients: effects of intervention with fish oil and corn oil. Scand J Clin Lab Invest 1993; 53: 499–506
- Selvais P L, Ketelslegers J M, Buysschaert M, Hermans M P. Plasma endothelin-1 immunoreactivity is increased following long-term dietary supplementation with omega-3 fatty acids in microalbuminuric IDDM patients [letter]. Diabetologia 1995; 38: 253